We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$605M
AUM Growth
+$125M
Cap. Flow
+$96.3M
Cap. Flow %
15.91%
Top 10 Hldgs %
10.86%
Holding
696
New
282
Increased
102
Reduced
88
Closed
224

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.1M
2
INCY icon
Incyte
INCY
+$6.78M
3
TGT icon
Target
TGT
+$5.96M
4
RMD icon
ResMed
RMD
+$5.78M
5
MSCI icon
MSCI
MSCI
+$5.72M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$46.8M
2
WYNN icon
Wynn Resorts
WYNN
+$5.62M
3
AAPL icon
Apple
AAPL
+$5.53M
4
NVS icon
Novartis
NVS
+$5.28M
5
WMT icon
Walmart Inc
WMT
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Consumer Discretionary 17.11%
3 Healthcare 16.08%
4 Industrials 11.44%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLI icon
251
Mueller Industries
MLI
$14.7B
$674K 0.11%
+30,896
New +$587K
SNPS icon
252
Synopsys
SNPS
$74.4B
$673K 0.11%
1,546
-10,237
-87% -$4.12M
OVV icon
253
Ovintiv
OVV
$17.3B
$666K 0.11%
+17,481
New +$632K
CHKP icon
254
Check Point Software Technologies
CHKP
$13B
$662K 0.11%
+5,266
New +$663K
IRDM icon
255
Iridium Communications
IRDM
$5.02B
$661K 0.11%
+10,639
New +$658K
WEC icon
256
WEC Energy
WEC
$35.7B
$657K 0.11%
+7,440
New +$687K
MAS icon
257
Masco
MAS
$14.1B
$656K 0.11%
+11,437
New +$599K
AES icon
258
AES
AES
$10.5B
$646K 0.11%
31,174
+10,798
+53% +$238K
BRO icon
259
Brown & Brown
BRO
$23.6B
$637K 0.11%
9,251
-4,774
-34% -$304K
RARE icon
260
Ultragenyx Pharmaceutical
RARE
$2.45B
$637K 0.11%
+13,804
New +$640K
AFL icon
261
Aflac
AFL
$64.9B
$636K 0.11%
+9,110
New +$610K
FL
262
DELISTED
Foot Locker
FL
$633K 0.1%
+23,351
New +$795K
ALLE icon
263
Allegion
ALLE
$13.4B
$633K 0.1%
+5,274
New +$576K
TGLS icon
264
Tecnoglass Holdings Inc.
TGLS
$1.93B
$632K 0.1%
+12,243
New +$544K
AZN icon
265
AstraZeneca
AZN
$263B
$632K 0.1%
4,413
-20,927
-83% -$3.08M
FTV icon
266
Fortive
FTV
$17.9B
$632K 0.1%
11,209
-11,115
-50% -$561K
FLR icon
267
Fluor
FLR
$7.01B
$620K 0.1%
+20,961
New +$601K
BF.B icon
268
Brown-Forman Class B
BF.B
$13.2B
$620K 0.1%
+9,277
New +$594K
SYY icon
269
Sysco
SYY
$40.8B
$618K 0.1%
+8,330
New +$616K
MANH icon
270
Manhattan Associates
MANH
$11.2B
$612K 0.1%
+3,061
New +$532K
DHI icon
271
D.R. Horton
DHI
$40B
$611K 0.1%
5,024
+2,253
+81% +$246K
APA icon
272
APA Corp
APA
$13.2B
$609K 0.1%
17,824
+10,756
+152% +$375K
NBIX icon
273
Neurocrine Biosciences
NBIX
$16.8B
$606K 0.1%
+6,430
New +$628K
GD icon
274
General Dynamics
GD
$104B
$606K 0.1%
2,815
-157
-5% -$33.9K
CWK icon
275
Cushman & Wakefield Ltd
CWK
$3.14B
$601K 0.1%
+73,412
New +$639K
9 10
11
12 13

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Seven Eight Capital held 696 positions worth $605M, up 26% from $480M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Seven Eight Capital deployed $96.3M of net new capital in Q2 2023, opening 282 new positions and adding to 102 existing holdings. Its largest new stake was AbbVie: 48,404 shares worth $6.52M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Carvana, an estimated $4.53M trimmed.

  • Seven Eight Capital's largest Q2 2023 buy was AbbVie: 48,404 shares worth $6.52M.
  • Seven Eight Capital added most to Las Vegas Sands in Q2 2023, an estimated $4.94M increase.
  • Seven Eight Capital's biggest Q2 2023 reduction was Carvana, cutting an estimated $4.53M.
  • Seven Eight Capital fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $46.8M.
  • Seven Eight Capital's ten largest holdings make up 11% of its $605M portfolio in Q2 2023.
  • Seven Eight Capital opened 282 new positions and closed 224 in Q2 2023.
  • Seven Eight Capital's portfolio value rose 26% quarter-over-quarter to $605M.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.